Seroprevalence of herpes simplex virus type 1 and type 2 in Turkey

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 10, 2006, Pages 1232-1236

  Dolar, N ^a   Serdaroglu, S ^a   Yilmaz, G ^a   Ergin, S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Genital herpes; Herpes simplex virus type 1; Herpes simplex virus type 2; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONDYLOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; GENITAL ULCER; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROSTITUTION; SEROPREVALENCE; SEXUAL BEHAVIOR; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; BLOOD DONORS; CONDYLOMATA ACUMINATA; CROSS-SECTIONAL STUDIES; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; OCCUPATIONS; PREGNANCY; PROSTITUTION; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TURKEY;

EID: 33750315761     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01766.x     Document Type: Article

References (36)

1. Yeung-Yue KA, Brentjens MH, Lee PC, Tyring SK. Herpes simplex viruses 1and 2. Dermatol Clin 2000; 20: 249-266.
2. Nahmias AJ, Lee FK, Beckman-Nahmias S. Seroepidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990; 69: 19-36.
3. Corey L, Wold A. Genital herpes. In: Holmes KK, Sparling PF, Mardh PA et al., eds. Sexually Transmitted Diseases, 3rd edn. Mc Graw-Hill, New York, 1999; 285-312.
4. Malkin JE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004; 11: 2-23.
5. Wald A. Sexually transmitted diseases. Dermatol Clin 1998; 16: 795-797.
6. Roest RW, Meijden WI, Dijk G et al. Prevalence and association between herpes simplex virus types 1 and 2-spesific antibodies in attendees at a sexually transmitted disease clinic. Int J Epid 2001; 30: 580-588.
7. Hook EWD, Cannon RO, Nahmias AJ et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 1992; 165: 251-255.
8. Holmberg Sd, Stewart JA, Gerer AR et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988; 259: 1048-1050.
9. Whitley RJ, Corey L, Arvin A et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988; 158: 109-116.
10. Whitley R, Arvin A, Prober C et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991; 324: 450-454.
11. Brown ZA, Benedetti J, Sekle S et al. Asymptomatic maternal shedding of herpes simplex virus at the onset of labor: Relationship to preterm labor. Obstet Gynecol 1996; 87: 483-488.
12. Rudnick CM, Hoekzema GS. Neonatal herpes simplex virus infections. Am Fam Physician 2002; 65: 1138-1142.
13. Bünzli D, Wietlisbach V, Barazzoni F et al. Seroepidemiology of herpes simplex virus type 1 and 2 in western and southern Switzerland in adults aged 25-74 in 1992-1993: A population-based study. BMC Infect Dis 2004; 4: 10.
14. Duran N, Yarkin F, Evruke C, Koksal F. Asymptomatic herpes simplex virus type 2 (HSV-2) infection among pregnant women in Turkey. Indian J Med Res 2004; 120: 106-110.
15. Eing BR, Lippelt L, Lorentzen EU et al. Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2. J Clin Microbiol 2002; 40: 407-413.
16. Jerome KR, Ashley RL. Herpes simplex virus and herpes B virus. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken, RH, eds. Manual of Clinical Microbiology. ASM Press, Washington, 1291-1303.
17. Reddy SM, Balakrishnan P, Uma S, Thyagarajan SP, Solomon S. Performance of two commercial enzyme-linked immunosorbent assay kits using recombinant glycoprotein G2 antigen for detection of herpes simplex virus type 2 specific antibodies. Clin Diagn Laboratory Immunol 2005; 12: 359-360.
18. Aksözek A, Özdamar M, Ergin S et al. Comparison of three commercial glycoprotein G-based enzyme immunoassays for detection of HSV-1/HSV-2 IgG antibodies in pregnant women and sex workers. Clinical Microbiology and Infection 2004; 11: 216.
19. Pebody RG, Andrews N, Brown D et al. The seroepidemiology of herpes simplex virus type 1 and 2. Sex Transm Infect 2004; 80: 185-191.
20. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. J Infect Dis 2002; 186: 3-28.
21. Malkin JE, Morand P, Malvy D et al. Seroprevalence of HSV-1 and HSV-2 infection in the general French population. Sex Transm Infect 2002; 78: 201-203.
22. Wutzler P, Doerr HW, Farber I et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations -relevance for the incidence of genital herpes. J Med Virol 2000; 61: 201-207.
23. Gottlieb SL, Douglas JM Jr, Schmid DS et al. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis 2002; 186: 1381-1389.
24. Patrick DM, Dawar M, Cook DA et al. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transm Dis 2001; 28: 424-428.
25. Howard M, Sellors JW, Jang D et al. Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada. J Clin Microbiol 2003; 41: 84-89.
26. van de Laar MJ, Termorshuizen F, Slomka MJ et al. Prevalence and correlates of herpes simplex virus type 2 infection: Evaluation of behavioural risk factors. Int J Epidemiol 1998; 27: 127-134.
27. Bünzli D, Wietlisbach V, Jeannin A. Epidemiology of herpes simplex virus type 1 and 2 in Switzerland: A population-based study. 42nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002; Abstract L-774.
28. Suligoi B, Cusan M, Santopadre P et al. HSV-2 specific seroprevalence among various populations in Rome, Italy. Italian Herpes Manage Forum Sex Transm Infect 2000; 76: 213-214.
29. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990; 69: 19-36.
30. Cusini M, Cusan M, Parolin C et al. Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy. Italian Herpes Forum. Sex Transm Dis 2000; 27: 292-295.
31. Garcia-Corbeira P, Dal-Re R, Aguilar L, Granizo JJ, Garciade-Lomas J. Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the Spanish general population? J Med Virol 1999; 59: 194-197.
32. Varela JA, Garcia-Corbeira P, Aguanell MV et al. Herpes simplex virus type 2 seroepidemiology in Spain: Prevalence and seroconversion rate among sexually transmitted disease clinic attendees. Sex Transm Dis 2001; 28: 47-50.
33. Vyse AJ, Gay NJ, Slomka MJ et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: Implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000; 76: 183-187.
34. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis, 1996; 174: 470-475.
35. Opaneye AA, Bashford J. Seroprevalence of antibodies to herpes simplex virus types 1 and 2 among two sexually active female populations in Middlesborough, England. J R Soc Health 2002; 122: 108-111.
36. Cunningham AL, Lee FK, Ho DW et al. Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics. Med J Aust 1993; 158: 525-528.